Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy

被引:74
作者
Tock, Lian [1 ]
Prado, Wagner L. [1 ]
Caranti, Danielle A. [1 ]
Cristofalo, Dejaldo M. J. [1 ]
Lederman, Henrique [1 ]
Fisberg, Mauro [1 ]
Siqueira, Kali O. [1 ]
Stella, Sergio G. [1 ]
Antunes, Hanna K. [1 ]
Cintra, Isa P. [1 ]
Tufik, Sergio [1 ]
de Mello, Marco Tulio [1 ]
Damaso, Ana R. [1 ]
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, UNIFESP, EPM, Sao Paulo, Brazil
关键词
adolescents; fatty liver; therapy; ultrasound; visceral adipose tissue;
D O I
10.1097/01.meg.0000243872.86949.95
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Despite the increasing prevalence of nonalcoholic fatty liver disease, its pathogenesis and clinical significance remain poorly defined and there is no ideal treatment. Objective The aim of this study was to assess the short-term (12-week) multidisciplinary therapy on visceral adiposity and nonalcoholic fatty liver disease control. Methods We evaluated and compared the distribution of visceral adiposity and nonalcoholic fatty liver disease, by ultrasonography, in 73 post-puberty obese participants (17.01 +/- 1.6 years old; body mass index 36.54 +/- 2.86 kg/m(2)), submitted to a multidisciplinary treatment without medications, at the beginning and after 12 weeks of intervention. Descriptive and one-way analysis of variance, and paired t-test were performed. Results The results indicated that after intervention the adolescents had a significant reduction in visceral adiposity (4.05 +/- 1.55 to 3.37 +/- 1.44) and nonalcoholic fatty liver disease prevalence (from 52 to 29% on the right side andfrom 48 to 29% on the left side). It is a positive result because nonalcoholic fatty liver disease can progress to cirrhosis, even in children and adolescents. Conclusions The short-term treatment suggests a profound impact on the control of obesity-related comorbidities in young people.
引用
收藏
页码:1241 / 1245
页数:5
相关论文
共 28 条
[1]   Recent concepts in non-alcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P .
DIABETIC MEDICINE, 2005, 22 (09) :1129-1133
[2]   Non-alcoholic fatty liver disease [J].
Alba, LM ;
Lindor, K .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) :977-986
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]  
[Anonymous], 1999, WHONCDNCS992
[5]  
Bouneva Iliana, 2004, Clin Liver Dis, V8, P693, DOI 10.1016/j.cld.2004.04.003
[6]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[7]   Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans [J].
Bruun, JM ;
Lihn, AS ;
Verdich, C ;
Pedersen, SB ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E527-E533
[8]  
*CDCP, 1999, PREV OV CHILD AD
[9]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[10]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360